Following the recent ban on importing Apple Watches to the United States, consumers are wondering about the consequences and what lies ahead for Apple. The ban was imposed by the U.S. International Trade Commission (ITC) in response to a complaint filed by Masimo, a medical technology company. The ITC ruled that a specific feature of Apple Watches, which enables blood oxygen level readings, infringed on Masimo’s patents for pulse oximetry. Despite having the power to veto within 60 days, the Biden administration decided not to intervene. As a result, Apple voluntarily halted the sale of its latest models, Apple Watch Series 9 and Ultra 2, in the USA, in accordance with the ITC order. It is important to note that the ban only applies to Apple Watches with the disputed light-based functionality. The Apple Watch SE, which lacks this feature, remains unchanged and available for purchase.
Masimo accuses Apple of various wrongdoings, including poaching its employees and stealing technology after discussions of potential collaboration. On the other hand, Apple claims that Masimo’s actions are a conspiracy to clear the way for its own smartwatch. Both companies have filed patent infringement lawsuits against each other, with Masimo accusing Apple of violating its patents as well.
Currently, Apple plans to appeal the ban to the U.S. Court of Appeals for the Federal Circuit in Washington. Meanwhile, the company is reportedly working on software changes that would allow the watches to function without infringing Masimo’s patents. However, Masimo argues that a software fix alone would not be sufficient as its patents also cover the hardware.
As the situation unfolds, it remains to be seen how Apple will navigate these legal challenges and find a solution. The company’s ability to resume importing and selling Apple Watches in the United States may depend on the success of its appeal and potential software modifications.